AI and Robots Set to Transform Drug Manufacturing

Pharmaceutical manufacturing is undergoing major structural change as regulators tighten expectations around contamination control, data integrity, and operational traceability. The EU's updated GMP Annex 1 guidance is pushing companies to reduce human involvement in production processes. Robotics and artificial intelligence are emerging as key tools to meet these demands, with industry analysts suggesting the shift may unlock significant efficiency gains and long-term value for drug manufacturers.